A citation-based method for searching scientific literature

Jia Ge, Michael Y Liu, Lei Li, Qing Deng, Feng Liu, Ying Luo, Lihong Wang, Guangyin Yao, Dandan Zhu, Huimin Lu, Mei Liang, Song Deng, Rong Zhou, Tao Luo. Int J Clin Exp Pathol 2020
Times Cited: 4







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Current and Emerging Applications of Droplet Digital PCR in Oncology.
Susana Olmedillas-López, Mariano García-Arranz, Damián García-Olmo. Mol Diagn Ther 2017
75
50

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
50

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
50

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
50

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
Daniel J Brat, Kenneth Aldape, Howard Colman, Eric C Holland, David N Louis, Robert B Jenkins, B K Kleinschmidt-DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp,[...]. Acta Neuropathol 2018
248
50

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
50

Implementation of cancer next-generation sequencing testing in a community hospital.
Yassmine Akkari, Tamara Smith, Jennifer Westfall, Stacie Lupo. Cold Spring Harb Mol Case Stud 2019
6
25

Droplet-Based Digital PCR: Application in Cancer Research.
G Perkins, H Lu, F Garlan, V Taly. Adv Clin Chem 2017
41
25

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
Joshua I Warrick, Gottfrid Sjödahl, Matthew Kaag, Jay D Raman, Suzanne Merrill, Lauren Shuman, Guoli Chen, Vonn Walter, David J DeGraff. Eur Urol 2019
74
25

Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing.
Ashleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, Michelle R Pereira, Robert Pearce, Lester Cowell, Cleo Robinson, Fabienne Grieu-Iacopetta, Alexander J Spicer, Benhur Amanuel,[...]. J Mol Diagn 2018
17
25

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Christopher G T Blick, Sarfraz A Nazir, Susan Mallett, Benjamin W Turney, Natasha N Onwu, Ian S D Roberts, Jeremy P Crew, Nigel C Cowan. BJU Int 2012
68
25

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
56
25

Urine markers for detection and surveillance of bladder cancer.
Evanguelos Xylinas, Luis A Kluth, Malte Rieken, Pierre I Karakiewicz, Yair Lotan, Shahrokh F Shariat. Urol Oncol 2014
63
25

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Emil Christensen, Karin Birkenkamp-Demtröder, Iver Nordentoft, Søren Høyer, Kirstin van der Keur, Kim van Kessel, Ellen Zwarthoff, Mads Agerbæk, Torben Falck Ørntoft, Jørgen Bjerggaard Jensen,[...]. Eur Urol 2017
90
25

Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays.
John J G Pritchard, Graham Hamilton, Carolyn D Hurst, Sioban Fraser, Clare Orange, Margaret A Knowles, Robert J Jones, Hing Y Leung, Tomoko Iwata. Urol Oncol 2020
2
50

The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.
Ashley N Gonzalez, Michael J Lipsky, Gen Li, Matthew P Rutman, Kimberly L Cooper, David M Weiner, Gina Badalato, Guarionex J Decastro, Sven Wenske, James M McKiernan,[...]. Urology 2019
8
25

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
22
25

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
39
25


Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
Yujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, Makoto Matsushita, Norihiko Kawamura, Yoko Koh, Kosuke Nakano, Cong Wang, Yu Ishizuya, Yoshiyuki Yamamoto,[...]. Cancer Sci 2019
27
25

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
Maria Zvereva, Eduard Pisarev, Ismail Hosen, Olga Kisil, Simon Matskeplishvili, Elena Kubareva, David Kamalov, Alexander Tivtikyan, Arnaud Manel, Emmanuel Vian,[...]. Int J Mol Sci 2020
3
33

Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract.
Philip Burnham, Darshana Dadhania, Michael Heyang, Fanny Chen, Lars F Westblade, Manikkam Suthanthiran, John Richard Lee, Iwijn De Vlaminck. Nat Commun 2018
55
25

The hTERT core promoter forms three parallel G-quadruplexes.
Robert C Monsen, Lynn DeLeeuw, William L Dean, Robert D Gray, T Michael Sabo, Srinivas Chakravarthy, Jonathan B Chaires, John O Trent. Nucleic Acids Res 2020
11
25

Interrater reliability: the kappa statistic.
Mary L McHugh. Biochem Med (Zagreb) 2012
25

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
Joshua J Meeks, Hikmat Al-Ahmadie, Bishoy M Faltas, John A Taylor, Thomas W Flaig, David J DeGraff, Emil Christensen, Benjamin L Woolbright, David J McConkey, Lars Dyrskjøt. Nat Rev Urol 2020
21
25

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
164
25

Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations.
Andrew J Colebatch, Tom Witkowski, Paul M Waring, Grant A McArthur, Stephen Q Wong, Alexander Dobrovic. Clin Chem 2018
8
25


Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma.
Ashleigh C McEvoy, Leslie Calapre, Michelle R Pereira, Tindaro Giardina, Cleo Robinson, Muhammad A Khattak, Tarek M Meniawy, Antonia L Pritchard, Nicholas K Hayward, Benhur Amanuel,[...]. Oncotarget 2017
30
25

Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.
Miguel F Sanmamed, Sara Fernández-Landázuri, Carmen Rodríguez, Ruth Zárate, María D Lozano, Leyre Zubiri, José Luis Perez-Gracia, Salvador Martín-Algarra, Alvaro González. Clin Chem 2015
170
25

Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.
Uttam Satyal, Abhishek Srivastava, Philip H Abbosh. Front Oncol 2019
14
25

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
Md Ismail Hosen, Mahdi Sheikh, Maria Zvereva, Ghislaine Scelo, Nathalie Forey, Geoffroy Durand, Catherine Voegele, Hossein Poustchi, Masoud Khoshnia, Gholamreza Roshandel,[...]. EBioMedicine 2020
13
25


The health economics of bladder cancer: an updated review of the published literature.
Christina Yeung, Tuan Dinh, Joseph Lee. Pharmacoeconomics 2014
95
25

Self-organization of G-quadruplex structures in the hTERT core promoter stabilized by polyaminic side chain perylene derivatives.
Emanuela Micheli, Matteo Martufi, Stefano Cacchione, Pasquale De Santis, Maria Savino. Biophys Chem 2010
17
25

Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Erik Kouba, Antonio Lopez-Beltran, Rodolfo Montironi, Francesco Massari, Kun Huang, Matteo Santoni, Michal Chovanec, Michael Cheng, Marina Scarpelli, Jie Zhang,[...]. Expert Rev Mol Diagn 2020
3
33

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.
Broderick C Corless, Gregory A Chang, Samantha Cooper, Mahrukh M Syeda, Yongzhao Shao, Iman Osman, George Karlin-Neumann, David Polsky. J Mol Diagn 2019
22
25

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.
Patrice Hodonou Avogbe, Arnaud Manel, Emmanuel Vian, Geoffroy Durand, Nathalie Forey, Catherine Voegele, Maria Zvereva, Md Ismail Hosen, Sonia Meziani, Berengere De Tilly,[...]. EBioMedicine 2019
18
25

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
938
25

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
25

New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.
Tunc F Ersoy, Vera C Keil, Dariusch R Hadizadeh, Gerrit H Gielen, Rolf Fimmers, Andreas Waha, Barbara Heidenreich, Rajiv Kumar, Hans H Schild, Matthias Simon. Neuroradiology 2017
8
25


Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
C Mircea S Tesileanu, Linda Dirven, Maarten M J Wijnenga, Johan A F Koekkoek, Arnaud J P E Vincent, Hendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, Sjoerd G van Duinen, Marion Smits,[...]. Neuro Oncol 2020
31
25

Telomerase-Targeted Cancer Immunotherapy.
Eishiro Mizukoshi, Shuichi Kaneko. Int J Mol Sci 2019
30
25

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
186
25

Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
Ji Eun Oh, Takashi Ohta, Naosuke Nonoguchi, Kaishi Satomi, David Capper, Daniela Pierscianek, Ulrich Sure, Anne Vital, Werner Paulus, Michel Mittelbronn,[...]. Brain Pathol 2016
38
25

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
25

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.
Einar Osland Vik-Mo, Marta Nyakas, Birthe Viftrup Mikkelsen, Morten Carstens Moe, Paulina Due-Tønnesen, Else Marit Inderberg Suso, Stein Sæbøe-Larssen, Cecilie Sandberg, Jan E Brinchmann, Eirik Helseth,[...]. Cancer Immunol Immunother 2013
133
25

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
148
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.